alexa Abstract | Development and validation of HPLC-UV method for the estimation of rebamipide in human plasma

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Paper Open Access

Abstract

A simple, rapid, selective and sensitive reversed phase HPLC method was developed and validated for the determination of rebamipide from plasma. The drug was extracted with a mixture of chloroform and isopropyl alcohol. Rebamipide was measured in plasma using a validated HPLC method with UV detection at 280 nm. Chromatographic peaks were separated on a 5 µm C-18 silica column using a mixture of acetonitrile, water, methanol and acetic acid as a mobile phase. The chromatograms showed good resolution and no interference from plasma.The retention time of rebamipide and internal standard were approximately 4.9±0.3 min and 7.6±0.3 min, respectively. The mean recovery from human plasma was found to be above 91%. The method was linear over the concentration range of 10 to 500 ng/ml with coefficient of correlation (r2) 0.991. Both intra-day and inter-day accuracy and precision data showed good reproducibility. This method can be successfully applied to pharmacokinetic studies.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): UR Manglani IJ Khan K Soni P Loya MN Saraf

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us